Olive AI
Olive AI raises $400M Series H at $4B valuation
Quick Facts
Olive AI: Series H Funding Round
Olive AI has successfully raised $400M in Series H funding, reaching a valuation of $4B.
Company Overview
Healthcare automation and AI platform
Funding Details
The Series H round was led by Vista Equity Partners, with participation from Tiger Global.
Company Information
- Headquarters: Columbus, OH
- Founded: 2012
- Employees: 800+
- Category: HealthTech
Investment
Olive AI plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Vista Equity Partners: Verified investor in Series H
- Tiger Global: Verified investor in Series H
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
